Undering blood concentration monitoring, precision medication of renal transplant patients of Voriconazole and immunosuppressive agents

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16008277

Enrollment

Unknown

Registered

2016-04-13

Start date

2016-04-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fungal diseases and transplant rejection control in renal transplantation

Interventions

1:Ivgtt Voriconazole

2:Po Voriconazole

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age more than 18 years.

Exclusion criteria

Exclusion criteria: (1) drug intolerance; (2) the severe liver function; (3)combination of rifampicin and isoniazid phenytoin, carbamazepine, long-acting barbiturate; (4) don't obey the medication guide; (5) the disease healed requirements discharged or transferred to other hospital patients.

Design outcomes

Primary

Measure	Time frame
Blood concentration;Clinical index;Dosage;	—

Countries

China

Contacts

Public ContactZhang Bikui

bikui_zh@126.com+86 13973116871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026